Israel Medica2010 Companies Catalogue - Israeli-South African ...
Israel Medica2010 Companies Catalogue - Israeli-South African ...
Israel Medica2010 Companies Catalogue - Israeli-South African ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
The <strong>Israel</strong> Export &<br />
International Cooperation Institute<br />
<strong>Israel</strong> at<br />
MEDICA 2010<br />
Hall 16 - G28, G37, G40 | Hall 5 - M19 | Hall 3 - E44<br />
November 17-20 | Düsseldorf, Germany
<strong>Israel</strong>: Life Science Powerhouse<br />
<strong>Israel</strong>i physicians, scientists, researchers and engineers have propelled the country's Medical Device industry to the<br />
leading edge of innovation and creativity, spanning all fields of medicine.<br />
Quick facts:<br />
• <strong>Israel</strong> is considered to be the second largest supplier of Medical Device solutions worldwide.<br />
• <strong>Israel</strong> ranks #1 in Medical Device patents per capita (#4 in absolute figures).<br />
• There are over 1,100 life science companies in <strong>Israel</strong>; 65% of them are Medical Device firms.<br />
Several global medical corporations have found <strong>Israel</strong>i companies to be attractive business partners. <strong>Israel</strong>i<br />
companies have proven their excellence in R&D, and in implementing breakthrough technologies in the Medical<br />
Device industry. Some of the leading multinationals holding equity positions in <strong>Israel</strong> include GE Medical, Philips,<br />
Siemens, Boston Scientific, Johnson & Johnson, and Medtronic.<br />
A strong entrepreneurial spirit pervades <strong>Israel</strong>i society. Perhaps fueled by a young country’s need to develop<br />
creative solutions quickly and cost-effectively, or inspired by improvisation and calculated risk-taking, it seems that<br />
innovation is an <strong>Israel</strong>i way of life.<br />
• <strong>Israel</strong>’s 16 Technology Transfer Organizations (TTOs) showcase the creative fusion between universities,<br />
hospital systems, businesses and the military. All of the TTOs are dedicated to encouraging and promoting<br />
research projects and military technology from the lab to the world market.<br />
• Healthcare is a priority in a well-educated country. <strong>Israel</strong> spends 8% of its GDP on healthcare. It boasts a very<br />
high level of healthcare and an extensive infrastructure of quality resources that range from local community<br />
clinics to world-renowned trauma centers. The country has a high ratio of MDs to population (3.5 per 1,000).<br />
The country’s entrepreneurial spirit runs through this sector as well: Many <strong>Israel</strong>i physicians are both early<br />
adopters of new technologies and developers of original technologies in their own right.<br />
• <strong>Israel</strong> has a highly skilled workforce. The country has the greatest number of scientists and engineers per<br />
capita in the world; 24% of the workforce have academic degrees.<br />
• The defense community nurtures the life science industry. Extensive investment in developing state-of-the-art<br />
technologies for defense has proved fertile ground for advanced life science applications. Two very wellknown<br />
innovations emerged from Rafael Advanced Defense Systems: PillCam TM , a video capsule endoscope<br />
(developed by Given Imaging), and cryotherapy for the treatment of cancer (developed by Galil Medical).<br />
• Strong institutional incentives support the development of new technologies. The 23 government-licensed<br />
technological incubators, which began in the 1990s as a way to provide employment opportunities for new<br />
immigrant scientists and engineers (many from the former Soviet Union), has evolved as a successful<br />
framework for advancing and commercializing early-stage life science technologies. In fact, in 2008,<br />
approximately 38% of the 1,175 incubator graduate companies continued beyond the incubator stage to<br />
function as mature companies.<br />
Nearly half of <strong>Israel</strong>’s technological incubators focus on the life sciences or biotechnology. At the end of 2008,<br />
41% of all incubated companies were involved in medical devices, and 18% in biotechnology. Of the $360<br />
million in grant money awarded to incubator companies by <strong>Israel</strong>’s Office of the Chief Scientist in 2008, 25.4%<br />
went to those involved in the life sciences.<br />
• The world’s venture capital community keeps its focus on <strong>Israel</strong>. In 2008, about 80 <strong>Israel</strong>i and international VC<br />
companies targeted specific investment efforts on <strong>Israel</strong>. Of these, nine are focused solely on life sciences.<br />
For more information:<br />
Ms. Angelica Khachaturov, Business Development Manger – Medical Device & Healthcare IT, <strong>Israel</strong> Export &<br />
International Cooperation Institute | Tel: +972-3-514-2986 | Fax: +972-3-514-2881 | angelica@export.gov.il<br />
2
The <strong>Israel</strong> Export & International Cooperation Institute (IEICI)<br />
The <strong>Israel</strong> Export & International Cooperation Institute, supported by member firms, private sector bodies<br />
and the government of <strong>Israel</strong>, advances business relationships between <strong>Israel</strong>i exporters and overseas<br />
businesses and organizations. By providing a wide range of export-oriented services to <strong>Israel</strong>i<br />
companies and complementary services to the international business community, the Institute helps build<br />
successful joint ventures, strategic alliances and trade partnerships.<br />
The IEICI’s Life Science Department is the leader in business matching between the more than 1,200<br />
companies in the <strong>Israel</strong>i life science industry and worldwide business partners at all levels. It has a<br />
proven ability to identify and match suitable potential business partners, organize one-on-one<br />
business meetings, and is a focal point for contacts with the government as well as with industry.<br />
The IEICI is the major organizer of <strong>Israel</strong>i company participation at Medica 2010.<br />
Visit the IEICI at Medica, Hall 16 Booth G40. www.export.gov.il/ls<br />
Foreign Trade Administration<br />
Ministry of Industry, Trade and Labor<br />
The Foreign Trade Administration of the Ministry of Industry, Trade and Labor manages and directs the<br />
State of <strong>Israel</strong>’s international trade policy. The Administration's main fields of activity include activities for<br />
the promotion of international trade and exports, negotiating and maintaining trade agreements for<br />
improving <strong>Israel</strong>’s trade network, attracting and encouraging foreign investments, and creating strategic<br />
alliances with foreign companies. In addition to its activities in <strong>Israel</strong>, the Administration operates a<br />
network of economic representatives, who act as the ministry’s operational arm in markets abroad.<br />
Objectives:<br />
• Assisting <strong>Israel</strong>i industry in deepening its activities in existing markets and penetrating new markets.<br />
• Accompanying and supporting individual exporters in their marketing activity abroad.<br />
• Negotiating and implementing international trade agreements, and maintaining existing agreements.<br />
• Promoting investments and strategic partnerships.<br />
• Promoting the image of the <strong>Israel</strong>i industry and economy abroad.<br />
For more information, visit www.trade.gov.il<br />
3
Table of Contents<br />
Medical Device <strong>Companies</strong> Index<br />
Aesthetics and Dermatology<br />
• Cnoga………………………………………………………………………………………………………... 16<br />
• CoolSense Medical………………………………………………………………………………………… 18<br />
• Erika Carmel………………………………………………………………………………………………… 23<br />
• TavTech……………………………………………………………………………………………………… 49<br />
Cardiovascular and Peripheral Vascular<br />
• BSP Biological Signal Processing………………………………………………………………………... 14<br />
• C-Boot……………………………………………………………………………………………………….. 15<br />
• Flexicath……………………………………………………………………………………………………... 26<br />
• HypnoCore…………………………………………………………………………………………………... 30<br />
• Itamar Medical……………………………………………………………………………………………… 32<br />
• VitalCare Medical…………………………………………………………………………………………... 50<br />
Diagnostics<br />
• 3QBD………………………………………………………………………………………………………… 8<br />
• BSP Biological Signal Processing………………………………………………………………………... 14<br />
• Cnoga………………………………………………………………………………………………………... 16<br />
• Common Sense……………………………………………………………………………………………... 17<br />
• Elitr Advanced Systems……………………………………………………………………………………. 20<br />
• Elsmed Medical Systems…………………………………………………………………………………... 22<br />
• Hypnocore…………………………………………………………………………………………………... 30<br />
• Itamar Medical……………………………………………………………………………………………… 32<br />
• Medoc………………………………………………………………………………………………………... 35<br />
• Sialo Technologies………………………………………………………………………………………… 44<br />
• SPO Medical Technologies………………………………………………………………………………... 47<br />
• VitalCare Medical…………………………………………………………………………………………... 50<br />
Disposable and Implantable<br />
• Albaad……………………………………………………………………………………………………….. 10<br />
• ETView……………………………………………………………………………………………………….. 24<br />
• First Care Products………………………………………………………………………………………… 25<br />
• Flexicath……………………………………………………………………………………………………... 26<br />
• Hanita Lenses……………………………………………………………………………………………….. 29<br />
• Intromedix…………………………………………………………………………………………………... 31<br />
• Mizra Medical……………………………………………………………………………………………….. 36<br />
• Sion Biotext Medical……………………………………………………………………………………….. 46<br />
Endoscopes and Accessories<br />
• Orpheus……………………………………………………………………………………………………... 39<br />
• Sialo Technologies………………………………………………………………………………………… 44
E.M.S.<br />
• Beth-El Zikhron Yaaqov Industries……………………………………………………………………… 12<br />
• ETView……………………………………………………………………………………………………….. 24<br />
• First Care Products………………………………………………………………………………………… 25<br />
• Flight Medical……………………………………………………………………………………………….. 27<br />
Gynecology and Women’s Health<br />
• 3QBD………………………………………………………………………………………………………… 8<br />
• ACU Medical Technologies………………………………………………………………………………... 9<br />
• Artisan Sonics………………………………………………………………………………………………. 11<br />
• Common Sense……………………………………………………………………………………………... 17<br />
• Elmedical…………………………………………………………………………………………………….. 21<br />
Hospital Equipment<br />
• Beth-El Zikhron Yaaqov Industries ……………………………………………………………………… 12<br />
• Coolsense Medical………………………………………………………………………………………… 18<br />
• EarlySense…………………………………………………………………………………………………... 19<br />
• Elsmed Medical Systems…………………………………………………………………………………... 22<br />
• ETView……………………………………………………………………………………………………….. 24<br />
• Flight Medical……………………………………………………………………………………………….. 27<br />
• Haldor Advanced Technologies………………………………………………………………………….. 28<br />
• Intromedix…………………………………………………………………………………………………... 31<br />
• NanoVibronix……………………………………………………………………………………………….. 37<br />
• OHK Medical Devices………………………………………………………………………………………. 38<br />
• Pegasus Medical Concepts……………………………………………………………………………….. 40<br />
• Polytex Technologies……………………………………………………………………………………… 41<br />
• Q-Core Medical…………………………………………………………………………………………….. 42<br />
• Shekel Scales………………………………………………………………………………………………... 43<br />
• SPO Medical Systems……………………………………………………………………………………… 47<br />
Infection Control and Infectious Diseases<br />
• Albaad………………………………………………………………………………………………………... 10<br />
• Beth-El Zikhron Yaaqov Industries………………………………………………………………………. 12<br />
• Mizra Medical……………………………………………………………………………………………….. 36<br />
• NanoVibronix………………………………………………………………………………………………. 37<br />
• Sion Biotext Medical……………………………………………………………………………………….. 46<br />
Industrial OEM<br />
• Albaad………………………………………………………………………………………………………... 10<br />
• B.R.F. Engineering…………………………………………………………………………………………... 13<br />
• Shekel Scales………………………………………………………………………………………………... 43<br />
Ophthalmology<br />
• Hanita Lenses ………………………………………………………………………………………………. 23<br />
• Sion Biotext Medical……………………………………………………………………………………….. 26<br />
• Talshir Medical Technologies…………………………………………………………………………….. 48<br />
5
Orthopedic<br />
• Erika Carmel ………………………………………………………………………………………………… 23<br />
• Flexicath…………………………………………………………………………………………………….. 26<br />
• Meditouch…………………………………………………………………………………………………… 34<br />
• OHK Medical Devices……………………………………………………………………………………..... 38<br />
• Sion Biotext Medical………………………………………………………………………………………. 46<br />
Respiratory and Pulmonary<br />
• ETView……………………………………………………………………………………………………….. 24<br />
• Flight Medical………………………………………………………………………………………………. 27<br />
• Hypnocore…………………………………………………………………………………………………... 30<br />
• Itamar Medical……………………………………………………………………………………………… 32<br />
Services<br />
• 2P2D Solutions…………………………………………………………………………………………….. 7<br />
• B.R.F. Engineering…………………………………………………………………………………………... 13<br />
• Medical Market Bridge……………………………………………………………………………………. 33<br />
• Signal Business Development……………………………………………………………………………. 45<br />
Telemedicine and Healthcare IT<br />
• 2P2D Solutions……………………………………………………………………………………………... 7<br />
• Artisan Sonix………………………………………………………………………………………………... 11<br />
• Elitr Advanced Systems……………………………………………………………………………………. 20<br />
• Hypnocore…………………………………………………………………………………………………... 30<br />
• Meditouch………………………………………………………………………………………………….... 34<br />
• Orpheus……………………………………………………………………………………………………… 39<br />
• Shekel Scales………………………………………………………………………………………………... 43<br />
Urology<br />
• Elmedical…………………………………………………………………………………………………….. 21<br />
• Mizra Medical……………………………………………………………………………………………….. 36<br />
• NanoVibronix……………………………………………………………………………………………….. 37<br />
Wound Management and Pain Management<br />
• C-Boot……………………………………………………………………………………………………….. 15<br />
• Erika Carmel………………………………………………………………………………………………… 23<br />
• Medoc………………………………………………………………………………………………………... 35<br />
• NanoVibronix……………………………………………………………………………………………….. 37<br />
• Sion Biotext Medical……………………………………………………………………………………….. 46<br />
6
2P2D Solutions Ltd.<br />
Back to TOC<br />
www.2p2d.com<br />
Company at a Glance<br />
2P2D Solutions Ltd. is a pioneering technology-based company developing unique solutions for various<br />
unmet needs within the healthcare, biotech and pharmaceutical industries.<br />
2P2D Solutions Ltd. has developed a breakthrough automated drug monitoring system for use in<br />
clinical drug trials that incorporates a portable, personalized medication dispensing device using<br />
proprietary 2P2D technology.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Medical Devices, Healthcare IT<br />
Telemedicine, Medication Management, Services, CRO<br />
Therapeutic Area(s):<br />
Company Status:<br />
R&D, Proof of Concept<br />
Technology & Product(s)<br />
• 2P2D Solutions Ltd. has developed ClinicAid, a breakthrough automated drug monitoring system that<br />
incorporates a portable medication dispensing device using proprietary 2P2D technology. The system<br />
dispenses personalized drug dosages designated for each specific patient or group of patients. For<br />
safety reasons, the drug is dispensed only after patient identification has been fully authenticated, and<br />
according to the designated clinical trial treatment regimen. This exclusive medication management<br />
system, for use in clinical drug trials, ensures unequaled compliance, accountability and accuracy.<br />
• The Company’s telemedicine solution provides:<br />
• Complete and real-time knowledge of the participant’s compliance and adherence to the trial protocols.<br />
• Reduced overall duration of the clinical trial period.<br />
• Increased participant compliance and adherence to the given medication.<br />
• Cost effective solution for clinical trial packaging and drug accountability.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Investment, Strategic Alliances<br />
CROs, pharma companies,hospitals<br />
Worldwide<br />
7
3QBD<br />
Back to TOC<br />
www.3qbd.com<br />
Company at a Glance<br />
Located in Arad, <strong>Israel</strong>, 3QBD Ltd. is an ISO certified startup medical device company. The company has<br />
developed the VGTest, a gynecological diagnostic device based on Ion Mobility Spectrometry (IMS) which is<br />
used in the detection of vaginal infections.<br />
In December 2009, 3QBD Ltd. received the European CE mark for the VGTest, a device capable of detecting<br />
and returning a positive/negative result for Bacterial Vaginosis, the most prevalent women’s vaginal<br />
infection, within 60 seconds.<br />
Future development plans for 3QBD include expanding research further into the medical field, to detect<br />
additional major infections and diseases and offer rapid, accurate results. Other applications for the<br />
technology include cancer, food and livestock.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Diagnostics<br />
Gynecology, Obstetrics, Women's Health<br />
Clinical Trials, Regulatory Approval<br />
Technology & Product(s)<br />
IMS (Ion Mobility Spectrometry) Technology<br />
3QBD's technology is based on the well-established and scientifically proven Ion Mobility Spectrometry<br />
(IMS) technology – first used successfully to detect drugs and explosives. Today IMS is being used to detect<br />
presence and type of infection.<br />
Chemical changes in living systems, or degradation of cells after death through enzymatic and microbial<br />
processes, are accompanied by the breakdown of amino acids and production of biogenic amines.<br />
Pathological conditions in the human body may be expressed in the formation of biogenic amines, so that<br />
elevated levels of biogenic amines may be indicative of dysfunctions. IMS is a sensitive instrumental<br />
technique for detecting volatile compounds. It is based on measuring the velocity of ions (ion mobility)<br />
drifting through a gas bath under the influence of an electric field.<br />
The Product<br />
The device works by measuring biogenic amines that are present at elevated levels in infections and<br />
diseases, and returns a rapid accurate result. In the case of Bacterial Vaginosis the result is provided within<br />
one minute. In addition, the VGTest for BV spares the physician from having to perform the Amsel Test and<br />
“whiff tests” of vaginal fluid, or spend time waiting for laboratory Gram Stain results.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Distribution, R&D Funding<br />
Women’s health professionals, gynecologists, obstetricians, hospitals and health<br />
clinics<br />
Worldwide<br />
8
ACU Medical Technologies <strong>Israel</strong><br />
Back to TOC<br />
www.easylabour.com<br />
Company at a Glance<br />
ACU Medical Technologies develops and markets the patent-protected EasyLabour® device to bring comfort<br />
to women giving birth.<br />
EasyLabour is a non-invasive, drug-free way to alleviate labour pain by conveniently and comfortably<br />
applying pressure to specific acupressure points in the lower back. Launched after a successful clinical trial<br />
that demonstrated a dramatic decrease in labour pain, EasyLabour has been widely accepted and<br />
recommended by major medical centers and endorsed by obstetric professionals. ACU Medical<br />
Technologies is staffed by a team of seasoned experts in pain medicine, obstetrics, midwifery, medical device<br />
engineering, product design and electro-mechanical engineering.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Medical Equipment<br />
Obstetrics, Women's Health<br />
Initial Revenues<br />
Technology & Product(s)<br />
EasyLabour ® conveniently and comfortably applies acupressure to six specific acupressure points, three<br />
points on each side of the spine, on the sacral foramina of a woman during labour.A dedicated clinical trial to<br />
determine the level of pain relief experienced was conducted in the obstetrics department of a large medical<br />
center.<br />
The results indicated that continuous rotational pressure applied to the sacral area while using the selfoperated<br />
electro-mechanical device was found to significantly reduce labour pain within five minutes.<br />
Preliminary indications also suggest a shorter pain period during a contraction while using EasyLabour.<br />
EasyLabour ® is a CE mark, Class I device. Several hospitals are now using EasyLabour ® worldwide as a<br />
complementary pain relief alternative.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Find distribution channels, locate leading end-use customers<br />
Hospitals (private and public), private obstetric clinics, independent professionals<br />
involved in obstetrics<br />
Worldwide<br />
9
ALBAAD<br />
Back to TOC<br />
www.albaad.com www.albaad.com/generalPage.aspx?pageID=Pharma<br />
Company at a Glance<br />
Albaad is one of the three leading producers of wipes worldwide. As a fully integrated converter owning<br />
production facilities in Germany, the US and <strong>Israel</strong>, global R&D, regulatory and production teams, Albaad is a<br />
preferred partner for numerous renowned multinationals and retailers.<br />
We don’t just make wet wipes; we make it our business to know everything there is to know about them,<br />
constantly studying customer needs, market trends and technological innovations.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Disposable, Industrial OEM, Accessories<br />
General Health, Infection Control<br />
Initial Revenues<br />
Technology & Product(s)<br />
Albaad has invested in the development and registration of a range of products intended for professional<br />
and consumer healthcare use. Our products are registered as medical device class 2a, FDA and EPA where<br />
applicable. Albaad will have been accredited ISO 13485 medical standard for its pharma production lines by<br />
the end of 2010.<br />
The range includes several surface and medical device disinfectants, hand hygiene, patient care and bathing<br />
kits, adult incontinence wipes and several consumer solutions, including natural fever relief, jellyfish relief,<br />
hemorrhoids relief and antiseptic wipes.<br />
Albaad wipes are one-step ready for use wipes, tailored to meet our customers’ special needs and<br />
requirements. They are made with soft fabrics and impregnated with gentle yet effective liquids. The wipes<br />
are produced and tested according to stringent standards and inspected by strict quality assurance<br />
procedures.<br />
Goal<br />
Objectives:<br />
Seeking strategic partners to leverage R&D, regulatory and production capabilities for<br />
development and sales to professional, institutional and consumer healthcare<br />
markets in Europe and worldwide.<br />
Target Businesses: Professional, institutional and consumer healthcare<br />
Target Countries:<br />
EU, Worldwide<br />
10
Artisan Sonics Ltd.<br />
Back to TOC<br />
www.artisansonics.com/Eng<br />
Company at a Glance<br />
Artisan Sonics is an <strong>Israel</strong>i software house serving the medical community in <strong>Israel</strong> since 1996. Our<br />
customers include Hospitals, Public Health Providers and Private Clinics. We specialize in streamlining the<br />
work of OB&GYN ultrasound (US) practitioners and their supporting staff, where our distinct leadership is<br />
well established. The streamlining concept is implemented through continuous fieldwork and close<br />
collaboration with doctors and other medical personnel. Identified needs transform into applications that<br />
solve the needs, thus streamlining the working environment, saving time and money. Our innovative<br />
solutions are engineered to enhance care quality, reduce risk, assure compliance and overall to improve the<br />
quality of clinical management. Essentially, these features provide a positive health outcome for our<br />
customers' patients. The aforesaid results are achieved by a strict commitment to maintaining the highest<br />
standards of quality. Artisan Sonics is led by Dr. Yoram Alperovitch, who has an extensive background in<br />
medical devices and IT applications. Dr. Alperovitch is supported by a steering committee whose members<br />
are world-renowned practitioners in the area of OB&GYN ultrasound.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices, Healthcare IT<br />
Diagnostic, PACS Archiving, Internet-based Health Information<br />
Obstetrics, Women's Health<br />
Revenue Growth<br />
Technology & Product(s)<br />
(a) Archiver – The Archiver is our flagship product. It allows the OB&GYN ultrasound (US) practitioner to<br />
save long video recordings of images, to transfer measurements from the US, to print reports of different<br />
exams while using a US machine for obstetric or gynecological scans. It shortens the reporting and<br />
documentation process by 25 to 45 percent. This extensive software is based on a dot.net and C++ client.<br />
(b) Pregnancy Supervision Package (PSP) – A Web application based on Linux and PHP allowing its users to<br />
perform pregnancy supervision. Data from the Archiver is automatically integrated into the PSP.<br />
(c) Visit Scheduling – A Web application allowing the scheduling of visits and appointments. The list of daily<br />
scheduled patients is automatically transferred into the Archiver.<br />
(d) Billing – A Web application to allow automatic generation of visit/exam bills. The scheduled visit exam<br />
type and patient details are automatically incorporated into the bill.<br />
(e) Remote Facility Exams Archiving – C++ client and IPVPN and Web technology for exams data dual storage<br />
in two separate locations; The backed up exams can be viewed through the Internet.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
To find agents and distributors<br />
Medical equipment representatives and resellers.<br />
Europe and Asia<br />
11
Beth-El Zikhron Yaaqov Industries<br />
Back to TOC<br />
www.BEInd.com<br />
Company at a Glance<br />
Beth-El Zikhron Yaaqov Industries Ltd. is a leading developer and manufacturer of Medical Negative Pressure Isolation<br />
Systems and Collective NBC Filtration Systems. Drawing on more than 30 years of experience in the air filtration field,<br />
Beth El Industries now offers the medical market an array of stationary and portable isolation chambers, clean/sterile<br />
rooms and stand-alone air filtration systems for various applications in hospitals and ground or airborne ambulances.<br />
Our isolation chambers series – IsoArk® – is designed to quarantine infected people and protect the atmosphere<br />
outside the chamber from contagious diseases like SARS, Ebola and TB.<br />
The main advantages of these devices are:<br />
• Allow for a quick and effective isolation<br />
• Simple and fast assembly that requires no additional tools<br />
• Completely portable (solution can be brought to the problem)<br />
• Come in a variety of sizes and can be custom made according to our client’s requests<br />
• Cost only a fraction of the price of a permanent stationary isolation room<br />
Certifications:<br />
Beth-El Zikhron Yaaqov Industries Ltd. is certified for ISO 9001:2000, AQAP-2110 and AS 9100 quality management<br />
systems, and is audited regularly by external entities.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Medical Equipment<br />
Emergency Medicine, General Surgery, Infection Control, Infectious Diseases, Veterinary<br />
Revenue Growth<br />
Technology & Product(s)<br />
• IsoArk - portable, negative pressure chamber designed for a rapid set up of a biologically isolated environment, for<br />
quick and effective isolation of contagious people and equipment. The system includes an airlock attached to the main<br />
chamber and an air filtration system. Special features of this system enable treating the patient from the outside,<br />
avoiding contamination of equipment and staff. All of the system components meet and exceed today’s standards for<br />
airborne infection isolation, including the CDC guidelines for healthcare control.<br />
• IsoArk N36-2 - portable chamber designed for transporting a single person under isolated conditions. IsoArk N36-2<br />
fits on any standard stretcher, and is ideally suited for use in ground and airborne ambulances. IsoArk N36-2 is<br />
equipped with its own negative pressure filtration system, an “all around” zipper and integrated gloves and utility<br />
portals. With the battery fully charged, the system can operate for up to 10 hours independently of an external power<br />
source and guarantees a complete isolation of the space inside the chamber during transport. The “collapsible,”<br />
lightweight structure allows for a quick set up of the system and minimal storage requirements when not in use.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
1. Agent, able to promote the products to the medical and emergency preparedness sectors<br />
in his country. 2. Contact with potential end customers<br />
Government agencies in charge of emergency prepardness, hospitals, importers and<br />
distributors, health ministry, ambulance and ambulance equipment companies,<br />
airports.<br />
Worldwide<br />
12
B.R.F. Engineering Ltd.<br />
Back to TOC<br />
www.brf-eng.com<br />
Company at a Glance<br />
B.R.F. is a hi-tech company based in Nazareth Illit, <strong>Israel</strong>. It is a leading provider of comprehensive end-toend<br />
integrated outsourcing solutions for OEMs. B.R.F. designs, develops and manufactures complete<br />
packaged products and provides after-market services for its OEM customers.<br />
B.R.F. offers its innovative and integrated technologies of design, development and manufacturing<br />
supporting the company’s professional and social vision principles:<br />
• Facilitating and improving the customer's level of operations.<br />
• Lowering design and development costs.<br />
• Lowering production costs.<br />
• Reducing time to market (TTM).<br />
• Social responsibility.<br />
• Obtain, protect and leverage intellectual property rights to our designs.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Services<br />
Subcontractor, OEM, Robotics, Medical Equipment, Research Equipment<br />
Therapeutic Area(s):<br />
Company Status:<br />
Revenue Growth<br />
Technology & Product(s)<br />
• Machine design for the high-tech, bio-tech, microelectronics and food industries.<br />
• Electronic packaging design, starting from the initial setting, production file and product prototype.<br />
• Industrial machine design.<br />
• Mechanical guidance and backup ending with current production in short timetables.<br />
• Finite Elements Manufacturing Analysis (FEA).<br />
• Computer aided design services (CAD).<br />
• Technical writing (user manual including operational methods, assembly process and test procedures),<br />
and brochures.<br />
• In-house production.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Medical OEMs<br />
Medical OEMs<br />
Europe and America<br />
13
BSP Biological Signal Processing Ltd.<br />
Back to TOC<br />
Company at a Glance<br />
www.bspmedical.com<br />
Founded in 2000, BSP Biological Signal Processing Ltd. is a medical device company with corporate offices<br />
in Tel Aviv, <strong>Israel</strong> and a US subsidiary – BSP, Inc. – with sales and marketing offices in Rockville Maryland, US.<br />
BSP is publicly traded on the Tel Aviv Stock Exchange since 2006 (TASE:BSP).<br />
BSP develops and commercializes a new generation of systems for non invasive diagnosis and monitoring of<br />
Ischemic Heart Disease (IHD), based on advanced signal processing of the ECG signal which integrates the<br />
Company’s unique, patented, HyperQ technology.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Diagnostics<br />
Cardiovascular<br />
Initial Revenues<br />
Technology & Product(s)<br />
BSP has pioneered the clinical implementation of high-frequency ECG and has developed it into a fast,<br />
accurate, low-cost, simple to operate and non-radiating technology for detecting IHD with greater clinical<br />
value than the current standard ECG. The company’s proprietary HyperQ technology extracts and analyses<br />
the high-frequency components of the ECG and provides a unique diagnostic index. Thousands of patients<br />
have been tested with the HyperQ system to date, demonstrating consistently that HyperQ is far superior to<br />
conventional ECG both in sensitivity and specificity, with the potential to save up to 50% of the unnecessary<br />
radioactive imaging procedures, while improving the standard of care. BSP’s intellectual property portfolio is<br />
backed by four granted patents and 14 filed applications in different stages.<br />
HyperQ EX-300 Stress System: The HyperQ EX-300 Stress system enables an accurate and risk-free<br />
procedure for the early diagnosis of Ischemic Heart Disease (IHD). HyperQ stress testing is performed in a<br />
similar manner to a standard clinical stress test, providing the conventional stress ECG results, and the<br />
HyperQ test results, with extraordinary clinical accuracy. The system is offered as a combination of software<br />
and hardware that connects to a treadmill or stationary bicycle and constitutes a full ergometry (stress ECG)<br />
station that is FDA (510k) cleared and CE certified.<br />
Goal<br />
Objectives: The company’s primary strategic objectives include establishing HyperQ as the first line modality<br />
for monitoring and diagnosis of Ischemic Heart Disease in cardiology clinics, ambulatory and hospital<br />
settings, and attaining reimbursement code and premium coverage over competitors for the HyperQ<br />
diagnostic modality in the US. Growth in market penetration and market share will be achieved through a<br />
combination of business partnerships with equipment and healthcare service providers, and by the<br />
establishment of a global marketing and sales presence.<br />
Target Businesses: Distributors specializing in cardiovascular diagnostic devices, leading<br />
manufacturers in the field of cardiovascular diagnostic devices for potential business partnerships, leading<br />
health service providers.<br />
Target Countries:<br />
Worldwide<br />
14
C-Boot<br />
Back to TOC<br />
www.c-boot.com<br />
Company at a Glance<br />
C-Boot develops and manufactures advanced compression products for preventing and treating venous<br />
and lymphatic diseases and other conditions that require compression therapy, including DVT prevention.<br />
C-Boot offers the first intermittent pneumatic compression (IPC) line of products powered automatically by<br />
energy generated from the patient’s body.<br />
The company holds proprietary technological knowledge, patents covering the technological concept, and<br />
aspects in the field of low pressure compression.<br />
The first line of product is already generating revenues through sales to distributors. The company is now<br />
focused on expanding its worldwide presence.<br />
The manufacturing process is subject to stringent standards of quality assurance. All of C-Boot's products<br />
are FDA and CE approved, and the company has been granted the ISO 9001:2000 and ISO 13485:2003.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Medical Equipment<br />
Peripheral Vascular, Wound Care and Primary Care<br />
Initial Revenues<br />
Technology & Product(s)<br />
C-Boot’s patented system is a wearable sleeve comprising a unique pneumatic brain and several inflatable<br />
chambers that wrap the leg. Using the body’s own kinetic energy while an individual is walking, the system<br />
inflates the chambers in a gradient and sequential cycle which leads to blood release from both the<br />
superficial and deep veins. This strengthens the body's natural tendency to enhance lymphatic and venous<br />
return, and enables the blood to re-circulate toward the heart.<br />
C-Boot concept allows patients to maintain complete mobility without the need for cumbersome external<br />
pumps. The technology is protected by number of patents surrounding the use of kinetic energy to drive the<br />
pneumatic action, as well as the sophisticated internal mechanisms that allow for the pneumatic action to<br />
also be driven by a very small and portable compressor.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Distribution, Alliances<br />
Clinics, home care, orthopaedics and rehabilitation centers<br />
EU<br />
15
Cnoga Medical<br />
Back to TOC<br />
Company at a Glance<br />
www.cnoga.com<br />
Cnoga Medical is an innovative developer of easy-to-use, touch-free and non-invasive medical devices.<br />
Cnoga believes that the time is soon approaching when most blood tests will be conducted by the patients<br />
themselves, in the comfort of their own homes, and with a simple non-invasive device.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Monitoring<br />
Cardiovascular, Diabetics, Dermatology and Aesthetics, Hematology, Genetic<br />
Disorders, General Health<br />
Initial Revenues<br />
Technology & Product(s)<br />
Cnoga Medical’s technology provides a new patent pending and state of the art solution for the noninvasive/touch-free<br />
methods of measuring physiological parameters.<br />
Cnoga's technology is based on real-time tissue photography. Tissue image color is processed in real-time,<br />
providing temporary color distribution, using dynamic range of at least 36 color-depth representing over<br />
6.8^10 color combination. Then, by using a sophisticated mathematical algorithm, the vast amount of<br />
information is computed and analyzed for detecting the correlation between temporary color<br />
pigmentation and a specific bio or physiological parameter.<br />
Products:<br />
The Oximanometer – Pulse rate, blood pressure and SpO2 monitoring device<br />
The Hemoximeter – Hemoglobin, pulse rate, SpO2 monitoring device<br />
The Glucometer – Blood glucose, non-invasive, monitoring device<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Meet potential business partners and distributors, as well as potential customers<br />
Medical device distributors, hospitals and medical insurance companies<br />
EU<br />
16
Common Sense Ltd.<br />
Back to TOC<br />
Company at a Glance<br />
www.cs-commonsense.com<br />
COMMON Sense’s proprietary technologies enable the diagnosis of bacterial vaginosis (BV), trichomoniasis<br />
and amniotic fluid leakage through the non-invasive collection of vaginal secretions on panty–liners as well<br />
as on vaginal swabs.<br />
COMMON SENSE carries out R&D, manufactures and markets non-invasive OTC panty-liner home tests and<br />
OTC and OTC/Rx professional vaginal swabs for gynecologists, point of care and hospitals for the:<br />
1. Classification of common abnormal vaginal discharges and detection of acidity parameters associated<br />
with BV or trichomoniasis in symptomatic women.<br />
VI-SENSE (VI=Vaginal Infections) panty-liner and swabs kit<br />
2. Detection of amniotic fluid leakage.<br />
AL-SENSE (AL=Amniotic Leak) panty-liner kit<br />
3. Monitoring pregnant women with pre-term delivery history for asymptomatic BV infection and reduce<br />
risk of pre-term delivery.<br />
VA–Sense (VA=Vaginal Acidity) panty-liner kit<br />
4. Monitoring pH in asymptomatic women as an early warning for vaginal itching, odors and other<br />
symptoms.<br />
Norma-Sense panty- liner<br />
The company's inventions have been filed as US patents and PCT. The products are FDA and CE approved.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Diagnostic<br />
Gynecology, Women's Health<br />
Initial Revenues<br />
Technology & Product(s)<br />
COMMON SENSE Ltd.'s proprietary technology includes a range of indicator polymers that react with<br />
different pH levels, buffer capacity values, and ammonium ion concentrations by changing color from yellow<br />
to blue green, in the presence of vaginal secretions with elevated pH levels that indicate BV or trichomoniasis<br />
or an amniotic fluid leak.The resulting stain is stable for many hours, while the change in color due to the<br />
contact with urine is reversible.<br />
These kits providee, for the first time, the revolutionary ability to determine non-invasively the cause of<br />
abnormal vaginal discharge, and to identify amniotic fluid leakage. The company believes this technology to<br />
be applicable to a host of novel applications that until now have had no solution.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries: Worldwide<br />
COMMON SENSE Ltd.'s goal is to become the leading supplier of home and<br />
professional tests for common abnormal discharges, monitoring for abnormal pH<br />
levels, and detection of amniotic fluid leakage, as well as for other gynecological and<br />
urological conditions<br />
17
CoolSense Medical Ltd.<br />
Back to TOC<br />
Company at a Glance<br />
www.coolsense.net<br />
CoolSense Medical Ltd. is a subsidiary of the M.D. Clinic Group based in Tel Aviv, <strong>Israel</strong>; an established and<br />
prestigious medical health center whose specialty in non-surgical aesthetic procedures serves an extensive<br />
network of cosmetic treatment clinics.<br />
CoolSense Medical Ltd. was responsible for the R&D that preceded the manufacture of the innovative handheld<br />
CoolSense pain numbing applicator. CoolSense's successfully implemented concept offers medical<br />
personnel, aestheticians and the general public a revolutionary but simply operated instrument that<br />
eliminates the pain and discomfort of injection procedures. The CoolSense Pain Numbing Applicator,<br />
which has received CE approval, FDA certification, and the <strong>Israel</strong>i Certificate of Free Sale is in use worldwide.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Medical Equipment<br />
Diabetics, Dermatology, Aesthetics, Endocrinology, General Health, Nephrology<br />
Initial Revenues<br />
Technology & Product(s)<br />
The innovative CoolSense device, when applied to the skin immediately, anesthetizes the site of injection<br />
with no after effects. The CoolSense Pain-Free Injection Applicator has been accepted as an indispensable<br />
instrument for health care personnel when performing medical or cosmetic skin invasive procedures. The<br />
CoolSense Applicator is also an invaluable tool that greatly improves the quality of life for individuals who<br />
are obliged to undergo injection procedures on a daily basis.<br />
CoolSense acts within 3-5 seconds to do away with the stress and fear that is associated with receiving<br />
injections, the most common health-care procedure worldwide.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Finding potential distributors for main European countries.<br />
Distributors<br />
Germany, France, Switzerland, UK<br />
18
EarlySense Ltd.<br />
Back to TOC<br />
www.earlysense.com<br />
Company at a Glance<br />
EarlySense Ltd. is bringing to market the EverOn system, an automatic, continuous, contact-free patient<br />
monitoring system that accurately identifies high-risk patient conditions. Alerting caregivers immediately<br />
upon detecting such events enables earlier interventions, leading to reduced complications and costs.<br />
EarlySense is headquartered in Ramat Gan, <strong>Israel</strong> and employs a multi-disciplinary team of 25 engineers,<br />
physicists, physicians, nurses and marketing professionals working closely with clinical sites worldwide. The<br />
Company’s vision is that within 10 years, all acute, chronic and geriatric patients will be continuously<br />
safeguarded with such continuous monitoring solutions in home and hospital settings.<br />
EarlySense's EverOn system bridges the critical time gap between patient deterioration and clinician<br />
intervention. In light of the Joint Commission’s 2009 Patient Safety Goals for healthcare organizations,<br />
EarlySense's technology offers a timely solution for detecting changes in a patient’s condition, while also<br />
helping nurses focus on the patients who need their immediate attention.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Medical Equipment, Monitoring<br />
General Health<br />
Initial Revenues<br />
Technology & Product(s)<br />
Technology<br />
EarlySense's technology is based on advanced signal-processing algorithms developed and refined over<br />
years of extensive in-vivo testing. The patented systems include ultra-sensitive components that monitor<br />
patients without direct contact or the need for patient compliance. The algorithms enable clinically accurate<br />
tracking and measurement of respiration and heart rates, as well as patient movement, including bed<br />
entry/exit and patient turn verification as indicated by a nurse interface.<br />
Automatic System Operation<br />
EarlySense’s technology has three main components: 1) a unique single plate sensing unit; 2) a bedside unit<br />
that processes and displays the measured data; and 3) a central station display that enables complete<br />
coverage of a unit wide set of monitors at a single point and enables an interface to the nurses’ mobile<br />
devices. Once placed under a bed mattress, the sensing unit immediately self-activates whenever the patient<br />
is in bed. The continuously filtered, sampled and analyzed data can be stored, and if desired can be printed<br />
for documentation and clinician analysis. The system is FDA and CE cleared and has been shown to improve<br />
clinical outcomes in general care units.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
To be a market leader in the Medical Supervision Field<br />
Sales in USA, major clinical study at Harvard/leading university<br />
USA, the Netherlands, Italy and Germany<br />
19
Elitr Advanced Systems Ltd.<br />
Back to TOC<br />
Company at a Glance<br />
www.elitr.com<br />
Elitr Advanced Systems Ltd. is a medical device company founded in <strong>Israel</strong> in 2005. The company’s mission is<br />
to offer a full range of non-invasive, multi-parameter patient monitoring devices and health management<br />
software tools to the full satisfaction of its customers and end-users.<br />
Elitr stations can be used for preventive screening for emergency room of national hospitals<br />
Elitr develops and manufactures distinct and innovative products hardware and software.<br />
The company's unique approach encourages the adoption of a preventative medicine and healthy lifestyle by<br />
simplifying the diagnosis and implementation processes by health stations, both of the individual and for the<br />
accompanying professionals.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices, Healthcare IT<br />
Diagnostic, Monitoring, Telemedicine, SW & HW, Biometrics<br />
Primary Care, General Health, Cardiovascular, Diabetics, Obesity<br />
Initial Revenues<br />
Technology & Product(s)<br />
Elitr provides: health station, specially designed to meet the needs of individuals and organizations that<br />
either wish to cut down their costs (e.g. hospitals and retirement homes), to increase their profits (e.g.<br />
pharmacy chains and gyms), or to improve their health and nutrition management.<br />
The health station provides gold standard measurement of some or all of the following vital signs: height,<br />
weight, BMI (Body Mass Index), RMR (Resting Metabolic Rate), hand grip strength test, body composition,<br />
blood pressure, pulse rate, electrical activity of the heart (EKG), heart rhythm regularity oxygen saturation,<br />
body temperature – all through a quick, non-invasive, single-posture process.<br />
In addition, they can be complemented by external monitoring devices.<br />
Elitr’s health station are automatically subscribed to the complementary health and weight management<br />
software BioFat, and can be subscribed to any other external database, including electronic medical records<br />
(EMRs). Telehealth MultiNurse, Elitr's most advanced health station model, also includes video conferencing<br />
and other telecommunications features, and it can also be compatible with the medical magnetic or smart<br />
card.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
To establish a worldwide distribution network, joint ventures with customers or<br />
distributors of diagnostic devices, health insurance companies<br />
Hospitals, private clinics, medical devices distributors, health spa channels,<br />
pharmacies<br />
Europe, Asia, North Africa, Middle East<br />
20
Elmedical Ltd.<br />
Back to TOC<br />
Company at a Glance<br />
www.elmedical.co.il<br />
Elmedical offers practical and better solutions for two unmet urological diseases: non-muscle invasive<br />
bladder cancer (NMIBC) and chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). In both diseases,<br />
other emerging thermal treatments already showed proof of concept and resulted in multiple procedures<br />
for each patient over the years. NMIBC and CP/CPPS are treated successfully by the company's office-based<br />
system (compact console and disposable catheters), which is approved in Europe and <strong>Israel</strong> as a urological<br />
thermal treatment platform. Elmedical's innovative solutions in these diseases offer superior clinical results<br />
and better economics.<br />
In the future, the company's platform plans to cover two more unmet urological diseases: overactive bladder<br />
(OAB) and interstitial cystitis/bladder pain syndrome (IC/BPS). In addition, Elmedical is aiming for its "hot<br />
urology solutions" to become the market preferred solutions in the four unmet diseases.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Minimally Invasive Systems<br />
Urology, Gynecology, Oncology<br />
Initial Revenues<br />
Technology & Product(s)<br />
Elmedical's proprietary non-ablative high temperature innovative technologies UniThermia and DuoThermia,<br />
covered by issued and pending patents, have clear and unique advantages over the other emerging thermal<br />
treatments in NMIBC and CP/CPPS.<br />
The company's BWT (Bladder Wall Thermochemotherapy) treats NMIBC with uniform hyperthermia<br />
(UniThermia) all over the bladder with a high flow of a heated chemotherapy solution. The BWT powerful<br />
heat-chemotherapy synergy is very effective and has practically no adverse events.<br />
DuoThermia provides simultaneous thermal treatments to the prostate (by a heated balloon) and bladder<br />
(by a heated saline circulation) to treat CP/CPPS where it prevails, the prostate and bladder, with dedicated<br />
heat sources and the other pelvic organs with the heated blood perfusion.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
To find a strategic partner and/or national distributors, established in urology, to<br />
market and sell the company's unique technology worldwide<br />
Cooperation with a strategic partner/distributors to develop the market in the<br />
unmet urological diseases and to support the clinical and regulatory processes in<br />
various countries<br />
Europe, <strong>South</strong> America, Asia and the US<br />
21
ElsMed Medical Systems Ltd.<br />
Back to TOC<br />
www.elsmed.com<br />
Company at a Glance<br />
ElsMed is a worldwide medical equipment supplier with extensive experience and known for high quality,<br />
fully refurbished diagnostic imaging medical equipment at an affordable price point. We have built our<br />
reputation for being the most trusted professional source for top quality and reliable equipment, service,<br />
parts and technical support.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Diagnostic, Imaging, Training, Medical Equipment<br />
General Health<br />
Revenue Growth<br />
Technology & Product(s)<br />
Our capabilities range from providing completely refurbished medical equipment, supplying all spare parts<br />
and ongoing service with extremely fast response time and On-Line Remote-Diagnostic support in real time.<br />
Our services range from initial consultation and evaluation, to complete turn-key projects for all diagnostic<br />
imaging centers and hospitals. Our staff includes the most experienced field engineers and factory trained<br />
support specialists for CT, MRI, NM, PET, Ultrasound and other technologically advanced systems.<br />
We service and support over 150 systems worldwide. ElsMed will be your first partner in providing low-cost,<br />
high-end medical equipment and service to any imaging diagnostic centers worldwide.<br />
Products:<br />
• Computer Tomography Systems<br />
• Nuclear Medicine Systems<br />
• MRI<br />
• ULS<br />
• NM Diagnostic Workstation<br />
• CT Diagnostic Workstation<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Looking for dealers of refurbished medical equipment and turn-key projects for<br />
medical venters<br />
Medical Imaging<br />
Worldwide<br />
22
Erika Carmel Ltd.<br />
Back to TOC<br />
www.gd-energies.com<br />
Company at a Glance<br />
As a company whose goal is to bring innovations in treatment, care, and quality of life to more and more<br />
people, we are proud to present you with cutting edge technology in soft laser therapy: B-Cure Laser is the<br />
world's first portable soft laser medical device WITH THE HEALING POWER OF A CLINIC.<br />
B-CURE Laser is recommended by the best pain specialists and is used widely in <strong>Israel</strong> by the leading pain<br />
clinics, wound healing clinics, and orthopedic departments in the following hospitals: Hadassah-Jerusalem,<br />
Sourasky, Rambam, and Sheba (Tel Hashomer). It is also used by the physiotherapy clinics of <strong>Israel</strong> Defense<br />
Force, leading sports clubs, and the best sportsmen in <strong>Israel</strong>, as well as by thousands of individuals for selftreatments<br />
at home.<br />
On January 2010 B-Cure Laser received the European CE 0120 approval for 16 indications and is presently<br />
being exported to some European countries.<br />
CE 0120 approved indications of B-Cure Laser are: knee pain, pain in neck, lower and upper back, sports<br />
injuries, muscle pain, arthritis, fibromyalgia, tennis elbow, Achilles tendonitis, carpal tunnel syndrome,<br />
inflammation, wound healing, burns, fresh surgical scars, post-pregnancy stretch marks, acne, herpes<br />
simplex, dental medicine, acupuncture.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Medical Equipment<br />
Orthopedic, Wound and Pain Management, Dermatology, Rehabilitation<br />
Revenue Growth<br />
Technology & Product(s)<br />
B-Cure Laser- LLLT 808- Low Level Laser Treatment<br />
The soft-laser effects the skin’s surface and simultaneously penetrates the skin without heating or hurting<br />
the skin.<br />
Soft laser treatment biostimulates the body’s natural healing mechanisms on a cellular and systemic level.<br />
The result: each kind of cell receives the energy required for activation of its optimal functioning in the body,<br />
thus allowing it to “self-heal” and naturally overcome specific problems.<br />
B-CURE LASER - an international breakthrough in soft laser therapy for professional and personal treatment<br />
of the aforesaid indications.<br />
Thanks to an exclusive, patent-pending development, we have created an exceptional combination: the<br />
power and full coherence of a clinic's soft laser device over a large area of 4.5 cm², with a portable,<br />
rechargeable, safe and easy-to-use device – all at a reasonable price.<br />
The result: a perfect combination of the most effective therapy with the ability to provide immediate and<br />
continuous treatments, thus enabling high quality and fast recovery in shorter individual treatment times,<br />
and with less total healing time.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Distribution<br />
Clinics, hospitals, sports teams, athletes, security forces, home care, nursing homes,<br />
and individuals for self-treatment at home.<br />
EU, USA, <strong>South</strong> America, Australia<br />
23
ETView<br />
Back to TOC<br />
www.etview.com<br />
Company at a Glance<br />
ETView manufactures the Tracheoscopic Ventilation Tube (TVT), an endotracheal tube fitted with a camera<br />
and light source for continuous monitoring of the airways.<br />
The TVT is the ideal tube for airway management, as it reduces the occurrences of difficult intubation while<br />
providing hospitals with a 100% verification of tube location and pinpointed suctioning of secretion<br />
buildup. By allowing for continous viewing of the airway, the TVT can minimize the amount of patient X-rays<br />
and should significantly reduce instance of VAP.<br />
The TVT is also sold as a trainer, and is the ideal device for teaching and refreshing intubation skills to<br />
medical students and emergency personnel.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Disposable<br />
Emergency Medicine, General Surgery, Intensive Care, Respiratory<br />
Revenue Growth<br />
Technology & Product(s)<br />
ETView’s patented, single-use tracheoscopic ventilation tube (TVT) incorporates a video camera and light<br />
source embedded in the tip of a conventional ventilation tube. The images from the TVT can be viewed on<br />
ETView's dedicated monitors, or on other monitors/computers.<br />
With a camera at this critical location, medical personnel can effectively monitor, identify, and perform<br />
suction on the buildup of secretions in both lungs, thereby significantly minimizing the risk of ventilatorassociated<br />
pneumonia.<br />
The TVT is indicated for use in the ICU, OR, ER and pre-hospital.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
To find distributors that will sell the TVT in their respective markets<br />
Distributors<br />
Worldwide<br />
24
First Care Products<br />
Back to TOC<br />
Company at a Glance<br />
www.firstcareproducts.com<br />
First Care Products specializes in the development and marketing of new products for pre-hospital<br />
emergency medical situations. The company's mission is to provide intelligent, innovative, effective and<br />
simple to use products which assist in life-saving, improve the treatment provided and yield significant<br />
savings in time and resources.<br />
Save One Life, Save A World<br />
Active in medical R&D, the company develops beneficial solutions for pre-hospital medical emergencies. First<br />
Care Products provides medics, first responders and the injured themselves with easy and quick to use,<br />
effective products for the control of hemmorhage resulting from trauma that save lives and greatly boost<br />
the treatment provided, whether on the battlefield, home front or accident scene. The company brings its<br />
years of comprehensive R&D and field experience to create products that, when every second counts, make<br />
the difference between life and tragedy.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Disposables<br />
Emergency Medicine<br />
Revenue Growth<br />
Technology & Product(s)<br />
The Emergency Bandage<br />
First Care Products' first and flagship product, The Emergency Bandage in all its versions has been<br />
designated as the "STANDARD" Personal Field Dressing by numerous major, quality military organizations,<br />
and is used by Special Forces and military medical corps worldwide. The Emergency Bandage is combat and<br />
clinically proven, being relied upon as an integral and vital component in the treatment of hemorrhage and<br />
trauma-related injuries.<br />
Beyond Military Use<br />
In addition to militaries around the world, First Care Products supplies its innovative bandages to<br />
governmental and private emergency medical services, Fire and Rescue, Police and Prison Authorities, First<br />
Aid and Survival Academies, and suppliers of first aid equipment to the general public.<br />
Worldwide Patent and Approvals<br />
First Care Products' bandages are patented worldwide, FDA and CE Approved, with health ministry approvals<br />
in each territory, NATO Reference Numbers, and NSNs in the USA. First Care Products manufactures all its<br />
products according to the highest International standards, including ISO 13485.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Strategic Alliances<br />
Worldwide<br />
25
Flexicath<br />
Back to TOC<br />
www.flexicath.com<br />
Company at a Glance<br />
Flexicath developed and market breakthrough catheter insertion systems to ensure simple, safe, and sterile<br />
intravenous catheterization.<br />
Addressing the need for a safe, easy-to-insert catheter for up to a 29-day treatment period, Flexicath has<br />
developed the M/29, a technology that combines a 30-day indweller IV catheter with special designed OTN<br />
introducers and an innovative 360 maximum barrier self-enclosed design to allow completely sterile<br />
insertion systems that are:<br />
• Safer and reduce risk of contact or airborne infections<br />
• Easier to use<br />
• More cost-effective, and do not require an external sterile environment<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Disposable, Implantable<br />
Hematology, Intensive Care, Internal Medicine, Oncology, Orthopedic, Pediatrics,<br />
Peripheral Vascular<br />
Initial Revenues<br />
Technology & Product(s)<br />
The M/29 combines a standard PICC line-type catheter that is completely enclosed in a sterile silicon sleeve<br />
and PeelGuard, a special silicone insertion unit. The sleeve creates a self-contained, sterile insertion field<br />
to form a 3D 360 maximum barrier.<br />
This design has several advantages:<br />
• Throughout the insertion procedure the catheter is fully encased and prevents touch and airborne<br />
contamination.<br />
• The system virtually eliminates blood backflow.<br />
• The insertion procedure is safe, simple, can be done by a floor nurse and is cost effective.<br />
• The M/29 has IV dwell time of up to 29 days<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Distribution, Alliances<br />
Industry leaders, manufacturers<br />
Germany, France, UK, Italy, Spain, <strong>South</strong> Africa, Australia<br />
26
Flight Medical<br />
Back to TOC<br />
www.flight-medical.com<br />
Company at a Glance<br />
Established in 1996, Flight Medical specializes in the development, manufacturing and marketing of<br />
respiratory life supporting equipment. Since its inception, Flight Medical had been focused on the high end of<br />
the portable ventilators market.<br />
Flight Medical develops and manufactures the HT50 (marketed worldwide exclusively by Newport Medical<br />
Instruments, Inc.), and its newly introduced Flight 60, both incorporating Flight Medical’s proprietary<br />
technology.<br />
To date over 12,000 Flight Medical ventilators have been helping patients worldwide, winning their<br />
reputation as a truly reliable, feature-loaded yet easy and intuitive to use portable ventilator.<br />
Flight Medical is a public company listed on the Tel Aviv Stock Exchange, with offices located in Lod, <strong>Israel</strong>.<br />
Flight Medical is a subsidiary of Medtechnica, <strong>Israel</strong>’s largest distributor of medical equipment.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Medical Equipment<br />
Emergency Medicine, Intensive Care, Primary Care, Pulmonary, Rehabilitation,<br />
Respiratory<br />
Revenue Growth<br />
Technology & Product(s)<br />
Flight Medical, the developer and manufacturer of the HT50 ventilator, which has been successfully used in a<br />
broad range of applications for over 10 years, is now offering an opportunity to participate in the launch of<br />
its new Flight 60 ventilator. Designed to continue the success of the 12,000 Flight Medical HT50 ventilators<br />
operating mainly in the United States and Japan, the newly introduced Flight 60 Ventilator offers even more:<br />
• Improved ventilation modes<br />
• Exhalation volume measurement<br />
• An intuitive 7" touch screen interface<br />
• 12 hours of battery life. Hot Swap capability provides practically unlimited independence<br />
• External communications<br />
The Flight 60 ventilator is a perfect fit for Home Care, Long Term Care, Transport and Hospitals<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Establish distribution network for our Flight 60 ventilator throughout the world.<br />
Distributors of medical devices, calling on Home Care, Long Term Care, Transport and<br />
Hospitals.<br />
Worldwide<br />
27
Haldor Advanced Technologies Ltd.<br />
Back to TOC<br />
www.haldor-tech.com<br />
Company at a Glance<br />
Haldor Advanced Technologies Ltd. specializes in integrating technological solutions that meet the business<br />
needs of the healthcare industry.<br />
The company was founded with a declared purpose to enhance surgical procedures with safe and efficient<br />
technological systems that will benefit doctors, surgeons, hospitals and, most importantly, patients.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Medical Equipment<br />
General Surgery<br />
Initial Revenues<br />
Technology & Product(s)<br />
ORLocate is an RFID-based system that counts, monitors, and tracks surgical instruments and sponges.<br />
ORLocate was designed to change the way Operating Rooms around the world perform counts and<br />
manage their assets. It is the first RFID technology system of its kind that offers an all-encompassing solution<br />
with automated counting and advanced tracking features that significantly enhance patient safety and<br />
maximize overall productivity and yield of hospitals, doctors and nurses.<br />
Human-related errors are attributed to faulty counting systems and negligible tracking procedures that are<br />
costing the United States healthcare industry over $2 billion annually. ORLocate offers hospitals a<br />
business opportunity to tap into long-term revenue schemes with a high Return on Investment while<br />
focusing on the highest industry standards for patient safety.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Seeking strategic marketing partner in Europe and <strong>South</strong>east Asia<br />
EMEA and SEA<br />
28
Hanita Lenses<br />
Back to TOC<br />
www.hanitalenses.com<br />
Company at a Glance<br />
Established in 1981, Hanita Lenses is <strong>Israel</strong>'s market leader and foremost manufacturer of Intraocular Lenses<br />
and Contact Lenses, with more than 60% of the local market.<br />
Hanita’s strategy focuses on innovation in R&D and technology, in order to maintain the company as a<br />
dynamic leading player in the ophthalmic medical device market.<br />
Hanita’s products are sold through a network of distributors throughout Europe, Asia, Latin America, and<br />
elsewhere.<br />
Lenses manufactured by Hanita Lenses meet the highest quality standard required by the European Union<br />
and carry the mark of approval:<br />
• European CE Mark<br />
• ISO 13485:2003 Medical Device Quality System<br />
• ISO 9001: 2000 Quality Systems<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Disposable, Implantable<br />
Ophthalmology<br />
Revenue Growth<br />
Technology & Product(s)<br />
Intraocular Lenses:<br />
Investments in stage-of-the-art equipment and technology, both in R&D and production, have placed Hanita<br />
in a leading position, enabling the company to compete in the fast-changing IOL market.<br />
New, advanced products are continually in the R&D pipeline. Hanita’s highly skilled team works in close<br />
collaboration with the company’s advisory board, comprising leading ophthalmic surgeons, and led by Prof.<br />
Ehud Asia.<br />
This collaboration allows the company to develop innovative intraocular lense designs that support new<br />
surgical techniques.<br />
Contact Lenses:<br />
Hanita Lenses manufactures and sells a broad range of GP, soft, conventional, special and disposable<br />
contact lenses, using the most advanced raw materials. Special designs, such as Toric Lenses, Keratoconus,<br />
Orthokeratology and lenses for dry eyes, are included in the range.<br />
The latest computerized techniques, as well as the state-of-the-art equipment, contribute to the excellence<br />
of our contact lens division.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Finding sutable distributors for Hanita Lenses products<br />
Opthalmic market, specifically the cataract field<br />
Europe - UK, Germany, Ireland, the Netherlands, Belgium, Spain, Scandinavia, Eastern<br />
Europe, Turkey, <strong>South</strong> Korea and Asia-Pacific<br />
29
HypnoCore Ltd.<br />
Back to TOC<br />
www.hypnocore.com<br />
Company at a Glance<br />
HypnoCore Ltd. was founded in 2006 with the vision of developing new methods to detect sleep disorders.<br />
The company was formed following over 10 years of successful academic collaboration between the<br />
founders, resulting in a technological breakthrough that has become the company's core technology.<br />
Mission Statement: HypnoCore is an innovative leader in the wellness and healthcare industries, and has<br />
revolutionized the field of sleep medicine by providing reliable, cost effective and user friendly sleep<br />
diagnostic solutions for home use that will help facilitate the treatment of chronic conditions and elevate the<br />
general quality of life.<br />
Medical Market Status:<br />
• CE, FDA approvals in 2008<br />
• Medical market services launched in Germany and <strong>Israel</strong> in 2010<br />
• Patent approved<br />
• Cooperation with leading <strong>Israel</strong>i corporate wellness companies<br />
• Consumer Business Status:•Full integration underway with Polar and Suunto heart rate monitors<br />
• Cooperation with Suunto in the wellness market<br />
• Research cooperation with Polar<br />
• Cooperation with the Wingate Institute - <strong>Israel</strong>'s leading sports institution<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Medical Devices<br />
Subcategory: Diagnostic, Monitoring, Telemedicine, Research Equipment, Training, SW & HW<br />
Therapeutic Area(s):<br />
Company Status:<br />
Technology & Product(s)<br />
Cardiovascular, Dental, Ear, Nose and Throat, General Health, Obesity, Primary Care,<br />
Respiratory<br />
Regulatory Approval<br />
In the medical market, HypnoCore technology enables the convenient collection of ECG data in people's<br />
homes and provides sleep laboratories with the opportunity for unlimited virtual expansion. With<br />
HypnoCore’s solutions, sleep laboratories and medical practitioners can expand their patient load to include<br />
multiple out-patients who simply send and receive their results and diagnosis over the web at a fraction of<br />
the cost of conventional in-patient procedures. The upgrade in the entire process will enable medical<br />
institutions to expand their patient populations without incurring major expenses.<br />
In the wellness and consumer healthcare market, HypnoCore technology will allow the average person to<br />
evaluate and improve his sleep on his own. In the initial stages, HypnoCore will offer a web application for<br />
sleep analysis and a guide on how to improve sleep, for heart rate monitor users of the most popular brands<br />
such as Polar, Suunto, Garmin, and others. These users are generally sportsmen, athletes and people<br />
independently seeking solutions or striving to improve their health and wellness.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Strategic Alliances<br />
Worldwide<br />
30
Intromedix<br />
Back to TOC<br />
www.intromedix.com<br />
Company at a Glance<br />
Intromedix is an <strong>Israel</strong>i manufacturer of premium quality, cost-effective, generic, disposable surgical<br />
equipment.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Disposable, Implantable, Medical Equipment<br />
General Surgery<br />
Revenue Growth<br />
Technology & Product(s)<br />
Surgical Sutures - absorbable and non-absorbable<br />
Surgical Staplers<br />
Skin Staplers<br />
Surgical Mesh<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Establish partnerships for distributing our products in key European countries.<br />
Distributors<br />
All European countries<br />
31
Itamar Medical<br />
Back to TOC<br />
Company at a Glance<br />
www.Itamar-Medical.com<br />
Itamar Medical Ltd. is a public traded (TASE: ITMR) bio-medical technology company. Itamar develops and<br />
markets noninvasive diagnostic medical equipment based on the proprietary PAT (Peripheral Arterial<br />
Tone) Signal. The PAT Signal serves as a noninvasive window to the Cardiovascular and Autonomic<br />
Nervous Systems.<br />
The PAT Signal is acquired by measuring pulsatile arterial volume changes in the fingertip by specialized<br />
noninvasive probes. Itamar’s FDA cleared and CE marked PAT-based products include:<br />
• Endo-PAT2000: noninvasive, office-based, user-independent device for endothelial function<br />
assessment – the precursor (earliest clinically detectable stage) of cardiovascular disease.<br />
• Watch-PAT200: ambulatory diagnosis of sleep-related breathing disorders and sleep staging<br />
(Wake/REM/Deep Sleep/Light Sleep stages).<br />
Both devices are used in preeminent clinical institutions, research centers and pharmaceutical clinical phase<br />
studies in over 40 countries, which have yielded nearly 300 publications.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Diagnostic<br />
Cardiovascular, Dental, Ear Nose and Throat (ENT), General Health, Internal Medicine,<br />
Neurology and Degenerative Disease, Peripheral Vascular, Primary Care, Respiratory<br />
Revenue Growth<br />
Technology & Product(s)<br />
Sleep testing - at home<br />
Considered “best in class,” WatchPAT (FDA cleared and CE marked) is a wrist mounted device for at-home<br />
testing of sleep apneas and sleep staging (REM/Deep Sleep/Light Sleep/Wake stages). WatchPAT also<br />
measures snoring & body position and provides a perfect combination of natural sleep at home with sleeplab<br />
level data.<br />
WatchPAT works without the multiple cables and electrodes needed by other technologies that provide indepth<br />
analysis of sleep, so it has an incredibly low failure rate. Yet the physician gets a comprehensive report<br />
with all the clinical parameters needed for patient treatment and monitoring. While the data are calculated<br />
automatically by the WatchPAT’s software, the physician can easily edit the data as well.<br />
Noninvasive cardiovascular risk assessment<br />
Atherosclerosis is the clinical manifestation of endothelial dysfunction. Leading the field of endothelial<br />
function assessment, EndoPAT (FDA cleared and CE marked) is used in pre-eminent clinical institutions,<br />
research centers and Pharma studies. The noninvasive EndoPAT has been validated by nearly 100<br />
publications and abstracts, and it provides clinicians with reliable and reproducible results in a 15-minute,<br />
office-based test.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Establish wide distribution network in Europe<br />
Distribution<br />
Brazil, Germany, UK, Spain, France<br />
32
Medical Market Bridge Ltd.<br />
Back to TOC<br />
www.mmbim.com<br />
Company at a Glance<br />
Medical Market Bridge (MMB) is an international marketing and business development company that acts as<br />
a bridge for medical device companies and rapidly brings innovative technologies to market success. MMB is<br />
actively present in a vast range of international medical device markets.<br />
MMB specializes in creating and managing revenue making sales channels for medical device companies.<br />
Each member of our group of 13 medical device experts is situated in his home country, where he has the<br />
experience and contacts to enable smooth market entry.<br />
MMB covers Europe, Pacific and Latin America.<br />
What do we do for our clients? For each manufacturing client, we match the best suited distributor, from a<br />
database of thousands. This important stage in the commercial lifecycle is done according to marketing<br />
strategy and local market characteristics. We strive to achieve a solid distribution agreement and manage<br />
the commercial interaction between the parties, being the manufacturer marketing office in each country.<br />
Low risk unique compensation model - MMB fees are success dependent. This means that our clients pay us<br />
only once real commercial activity has started.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Services<br />
Business Development<br />
Revenue Growth<br />
Technology & Product(s)<br />
MMB at Medica – B2B<br />
Our open booth at Medica will host B2B meetings, where manufacturers and distributors will discuss<br />
business collaboration.<br />
This is a great opportunity for creating new business partnerships.<br />
We invite manufacturers to participate in our B2B program, and make Medica an effective event.<br />
Distributors are also invited to contact us and see what we can offer to add to their product line.<br />
MMB represents several innovative technologies seeking distribution partners from Europe, Asia- Pacific<br />
region and Latin America.<br />
We are always glad to meet distribution companies and present our technologies to them.<br />
Currently, we offer technologies in Surgery, Urology, Gynecology, Orthopedics, Pain Management, Oncology,<br />
Anesthesia, Cardiology, Vascular Aurgery and more.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
MMB creates face to face meetings between manufacturers and distributors, and<br />
represents our current technologies<br />
Manufacturers and distributors of medical devices<br />
Worldwide<br />
33
MediTouch<br />
Back to TOC<br />
www.meditouch.co.il<br />
Company at a Glance<br />
MediTouch manufactures and sells innovative upper and lower limb active exercise systems with<br />
biofeedback trainers. The rehabiliation systems consist of gloves, elbow and leg braces, as well as dedicated<br />
rehabilitation software. The systems are designed to help patients recovering from stroke, traumatic brain<br />
injury, multiple sclerosis, cerebral palsy and incomplete spinal cord injury regain hand and leg movement.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Medical Equipment, Telemedicine, Training<br />
Cardiovascular, Neurology and Degenerative Disease, Pediatrics, Orthopedic,<br />
Primary Care, Rehabilitation<br />
Revenue Growth<br />
Technology & Product(s)<br />
HandTutor, ElbowTutor, LegTutor, AnkleTutor<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Looking to establish a wide distribution network<br />
Distributors<br />
Worldwide<br />
34
Medoc Ltd.<br />
Back to TOC<br />
www.medoc-web.com<br />
Company at a Glance<br />
Medoc is a leading manufacturer of neuro-diagnostic medical systems and advanced thermal stimulators<br />
for the assessment of chronic pain. Medoc's products evaluate the small and large peripheral sensory nerve<br />
fibers (A-delta and C fibers), constituting the "Pain Pathway."<br />
In 2006, Medoc established the Medoc <strong>Israel</strong> Division. This division represents companies worldwide,<br />
promoting and distributing their advanced medical solutions to the <strong>Israel</strong>i market. Medoc Ltd. has developed<br />
several strategic collaborations with leading international suppliers from the USA and Europe, including<br />
Boston Scientific, for treating severe and chronic pain patients by implanting advanced spinal cord<br />
stimulation (SCS) device, Neurotherm for treatment of local pain by applying Radio Frequency (RF) directly to<br />
the pain source, Epimed for nerve block solutions and catheters and HydroCision for minimal invasive<br />
discectomy.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Diagnostic<br />
Neurology and Degenerative Disease, Pain Management<br />
Revenue Growth<br />
Technology & Product(s)<br />
The PATHWAY Pain and Sensory Evaluation System offers new applications for advanced pain research and<br />
fMRI. The PATHWAY model CHEPS (Contact Heat-Evoked Potential Stimulator) marks a breakthrough in the<br />
field of pain-evoked potential, allowing objective assessment of evoked pain. The PATHWAY model ATS<br />
(Advanced Thermal Stimulator) and PATHWAY model CHEPS are currently used in fMRI studies and in<br />
advanced pain research.<br />
The TSA-II Thermal Sensory Analyzer is used in QST (Quantitative Sensory Testing) to clinically evaluate small<br />
nerve fibers (A-delta and C fibers). The VSA-3000 Vibratory Sensory Analyzer is used in the assessment of<br />
large peripheral nerve fibers (A-beta).<br />
The recently launched Computerized Algometer is a new software-based system, providing real-time visual<br />
and auditory feedback to control and monitor applied pressure rates.<br />
Medoc is also interested in expanding its scope of products in the <strong>Israel</strong>i market by signing partnership<br />
agreements with promising medical device companies offering breakthrough technology and innovative<br />
products.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Looking for representatives/distributors. Medoc is also interested in expanding its<br />
scope of products (for the <strong>Israel</strong>i market only), and in signing exclusive distribution<br />
agreements with promising non-<strong>Israel</strong>i medical device companies offering<br />
breakthrough technology and innovative products.<br />
Distributors; Medical device companies offering breakthrough technologies<br />
Distributors in China, Portugal, India. Medical device companies worldwide.<br />
35
Mizra Medical<br />
Back to TOC<br />
www.mizramedical.com<br />
Company at a Glance<br />
Mizra Medical Ltd. developed out of a family business, Mizra Latex Products, founded by Mr. Zeev Mizra in<br />
1955. The company was incorporated as Mizra Medical Ltd in 2002. The company has grown to be the<br />
leading producer of latex disposable products in <strong>Israel</strong>. Mizra's first factory was opened in Holon, <strong>Israel</strong>, a<br />
southern suburb of Tel Aviv. The company has expanded and our main manufacturing plant is now located<br />
close to the Port of Ashdod. We carry a complete line of continence care products and distribute specialized<br />
products that provide solutions to the challenges faced by the elderly, handicapped, or anyone with special<br />
needs.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Disposable<br />
General Health, Urology, Infection Control<br />
Revenue Growth<br />
Technology & Product(s)<br />
Mizra Medical carries an extensive line of continence care products, and distributes specialized products<br />
that provide solutions to the challenges faced by the elderly, handicapped, or anyone with special needs.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Distribution, Alliances<br />
Distributors, Hospitals, Pharmacies<br />
Eastern Europe, USA, Canada, <strong>South</strong> America<br />
36
NanoVibronix<br />
Back to TOC<br />
Company at a Glance<br />
www.nanovibronix.com<br />
NanoVibronix develops innovative medical devices based on its proprietary therapeutic acoustic<br />
technology.<br />
The company's two main product lines are for catheter-related complications and for treatment of wounds,<br />
soft tissue and pain in a range of clinical applications.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Therapeutic Device (Personal Ultrasound)<br />
Infection Control, Urology, Wound Management<br />
Initial Revenues<br />
Technology & Product(s)<br />
UroShield - prevents biofilm formation on catheters, thereby decreasing risk for urinary tract infection,<br />
increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.<br />
PainShield - accelerate healing of chronic wounds, bone fractures, non-union of fractures and relief of<br />
pain.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Expand distributor network<br />
Distributors<br />
Germany, France, Italy, UK, Spain, and Scandinavia<br />
37
OHK Medical Devices Ltd.<br />
Back to TOC<br />
www.hemaclear.com<br />
Company at a Glance<br />
The creators of HemaClear® saw the need for a new, different kind of tourniquet, one that would be simple,<br />
safe, sterile, and more cost-effective than any device on the market today. They had a vision, and realized it.<br />
HemaClear® is the first and only single-use device that exsanguinates, occludes, and provides a clearer<br />
surgical field. Beginning with a sterile field allows surgeons to place the device closer to the site than ever<br />
before. Its narrower size provides a larger, dryer, and clearer surgical field, for a better view of anatomical<br />
structures. Instant, on-the-spot sterility, and greater access to the surgical site assures a safer, more<br />
successful surgical outcome.<br />
Its innovative technology not only reduces blood loss, infection, and the volume of ischemic tissue, it’s<br />
simplicity saves precious OR set-up time…as much as fifteen minutes…and over 100 separate steps that<br />
can add as much as $300 to every procedure.<br />
In fact, HemaClear® is so revolutionary, it represents the single greatest advance in tourniquet technology<br />
since the Esmarch bandage.<br />
HemaClear® has been proven worldwide in over 150,000 surgical cases… from the OR…to disaster-struck<br />
areas all around the world (including the recent earthquake in Haiti).<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Medical Equipment, General Surgery<br />
Orthopedic<br />
Revenue Growth<br />
Technology & Product(s)<br />
HemaClear is designed to create a bloodless field for limb surgery, quickly and effectively without wasting<br />
precious time and materials. In the center of the device, a specially engineered silicone ring exerts just<br />
enough circumferential pressure as it rolls up the limb to exsanguinate completely and occlude the blood<br />
vessels -- without damaging soft tissue and nerves.<br />
Factory calibrated and pre-set, HemaClear delivers uniform and reproducible results. Full range of sizes to<br />
accommodate almost every patient type, from pediatric to obese (limb circumference of 14 to 90 cm).<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Develop a distribution network<br />
Orthopedic surgeons<br />
Germany, Belgium, the Netherlands, Switzerland, Scandinavia<br />
38
Orpheus<br />
Back to TOC<br />
www.orpheus.co.il<br />
Company at a Glance<br />
Orpheus is a spin-off of 4UTV, a company which was established on 1999 and was a pioneer in the area of<br />
digital broadcasting and video on demand, (VOD), systems.<br />
Orpheus is considered to be at the leading edge of its core technology, and it has deployed a large number of<br />
VOD systems worldwide.<br />
The company, headquarted in <strong>Israel</strong>, hires top of the line system engineers.<br />
By using our experience in the area of VOD we have developed a unique telemedicine system, MedicVOD,<br />
which enables a medical team to archive, view and re-use video assets that were recorded during a live<br />
medical procedure such as surgery, endoscopy, ultrasound, etc.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices, Healthcare IT<br />
Endoscope and Accessories, Telemedicine, Research Equipment, Training, Internetbased<br />
Health Information, PACS Archiving<br />
Gastrointestinal, General Surgery, Gynecology<br />
Clinical Trials, Regulatory Approval<br />
Technology & Product(s)<br />
The proposed system, MedicVOD, is a VOD (Video On Demand) system that enables a medical team to<br />
archive, view and re-use video assets that were recorded during a live medical procedure such as surgery,<br />
endoscopy, ultra sound, etc.<br />
The video/audio taken is captured directly from the scope camera monitor of the device being used.<br />
The system is based on a VOD core system, with selected add-on components completing a full system<br />
adapted to medical needs. Major features of MedicVOD include:<br />
1. Digital recording of the medical procedure directly to an on-site server<br />
2. Efficient archiving of video assets to save storage resources<br />
3. Live broadcasting of a medical procedure to an unlimited number of viewers<br />
4. Smart and efficient data fetching while using dynamic categories to produce various statistics and reports<br />
5. Ability to watch videos at any location and at any time<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Strategic Alliances<br />
1. Distributers specializing in the endoscopy field; 2. Manufacturers of endoscopes<br />
and accessories.<br />
Worldwide<br />
39
Pegasus Medical Concepts<br />
Back to TOC<br />
www.pegasusmedical.net<br />
Company at a Glance<br />
Pegasus Medical is a US-<strong>Israel</strong>i company dedicated to providing modular storage hardware solutions along with stock<br />
management and software tools used to manage and control the usage of medical supplies in the point of care<br />
surrounding.<br />
We manufacture a broad line of dedicated ISO ABS modules for storage.<br />
Our ISO modules are integrated in different "packages" – cabinets, open racks, trolleys, electronic cabinets etc.<br />
The Pegasus philosophy is to increase storage capacity per square meter by using "smart" storage hardware, with<br />
dedicated software tools. We help our clients arrange and plan the entire hospital disposable item supply chain from<br />
the warehouse to the department level.<br />
Unlike other players in the market, we combine basic entry-level solutions like storage racks, treatment trolleys and<br />
storage trolleys side by side with high-end solutions like secured electronic cabinets.<br />
We offer electronic and RFID cabinets, used to control expensive disposables items. These systems utilize dedicated<br />
software, providing the user with different logistic methodologies, including Scan to Take, RFID Recognition and<br />
Kanban Inventory.<br />
We are constantly looking for new partners to help us expand into new markets.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Medical Equipment<br />
General Health, General Surgery<br />
Revenue Growth<br />
Technology & Product(s)<br />
ISO Module – a broad line of 60X40 ISO trays, dividers and side panel systems.<br />
Storage Carts – multiple heights and width range of mobile storage carts for the ISO modules, including Tambour door<br />
and glass doors solutions. High quality – durable aluminum and HPL structure.<br />
Treatment and Resuscitation Carts – general procedure carts as well as resuscitation carts equipped with retractable<br />
slides, bumpers, abs top and a broad line of accessories.<br />
Open rack system – open rack system for ISO module with telescopic or fixed slide. Provided in a knocked down<br />
modular structure. Can be implemented by the end user!<br />
Cabinets – aluminum/melamine/SS cabinets for general department OR rooms and interventional cardiology units.<br />
Point of Use Stock Management Tools – Pegasus Kan ban point of use stock management tools enables hospital to<br />
maintain accurate stock level system without overloading the medical staff's work.<br />
SmartCab – Modular cabinets with scan to take technology or RFID technology for the management of high value items<br />
in ORs, Cath labs and Angio labs.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Expanding our network of distributors in Europe and <strong>South</strong> America<br />
Recruiting new distributors<br />
Europe in General, France, the Netherlands, Scandinavia, Italy, Hungary, Bulgaria,<br />
Poland and <strong>South</strong> America<br />
40
Polytex Technologies Ltd.<br />
Back to TOC<br />
www.polytex.co.il<br />
Company at a Glance<br />
Polytex Technologies Ltd. provides advanced solutions for textile management such as distribution of<br />
uniforms, garments, special wear for clean rooms, operating rooms scrubs, hotel towels, etc. The Polytex<br />
solution is based on unique, patented developments, which provides the Polytex systems' great advantages<br />
in terms of speed and reliability of service, capacity and costs. Our systems are installed at various sites from<br />
factories as Intel R&D center to medical centers, including Hadassah Medical Center in Jerusalem and Val<br />
d'Hebron in Barcelona.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Medical Equipment<br />
General Health<br />
Revenue Growth<br />
Technology & Product(s)<br />
Polytex products are divided into textile dispensing units and textile return units for various applications. All<br />
of our products are based on patented technology developed by Polytex. The Polytex technology allows our<br />
systems to distribute folded items. Compared to other existing solutions, our systems provides the best<br />
solution in terms of speed and reliability in distributing the textile items, speed in loading the items to the<br />
system, very low maintenance needs, high capacity and relatively low costs.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
To find potential clients and distributors<br />
Hospitals, industrial laundries, dealers and distributors of industrial machinery for<br />
laundries, dealers and distributors of hospital logistics systems<br />
Worldwide<br />
41
Q Core Medical Ltd.<br />
Back to TOC<br />
www.Qcore.com<br />
Company at a Glance<br />
Q Core Medical is a leading developer and producer of medical infusion and feeding pumps for hospital,<br />
home ambulatory and veterinary use. We are a dynamic and growing company that has been developing<br />
and producing advanced new technologies and products at the rate of one every 18 months.<br />
The infusion pumps market has become a distinct market segment of ~ $3B in 2008, to grow to over<br />
$4.5B by 2015. Smart pumps such as the Q Core’s AP34 are becoming the device of choice for hospital<br />
and ambulatory care due to the enhanced safety, convenience and efficiency they provide. Our<br />
conveniently readable screens, easy programming and fail-safe operation make the healthcare<br />
professional's job that much easier. For the patient, Q Core's ambulatory pumps make homecare possible<br />
at a previously unachievable level of quality of life, while our veterinary pumps are reliably accurate no<br />
matter how rugged the conditions.<br />
Q Core Medical is privately owned company acquired in 2009 by Dr. Boaz Eitan. Prior to the acquisition of<br />
Q Core, Dr. Eitan became the owner of over 80 patents and founded Saifun Semiconductors Ltd., which<br />
later merged with Spansion Semiconductors. Dr. Eitan serves as CEO and Chairman of the Board of Q Core<br />
Medical.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Drug Delivery<br />
General Health, Oncology, Pediatrics, Prenatal, Veterinary<br />
Initial Revenues<br />
Technology & Product(s)<br />
Q Core Medical has developed multi-treatment, epidural, pain management and veterinary pumps.<br />
Alongside these pumps Q Core offers a wide selection of accessories including ergonomic bolus handles,<br />
cradles, and all types of disposable sets necessary for use with our platform.<br />
Our unique patents and development skill together with production and business understanding allow Q<br />
Core Medical to offer its innovative products at best cost structure in class, as well as a superior, fast<br />
paced product roadmap.<br />
All of Q Core’s pumps include Magnetic Flow Control technology (mcf), which dramatically reduces the<br />
power consumption level, flow accuracy and enhances the continuous nature of the flow, thereby<br />
increasing patient safety.<br />
The Magic Straw is Q Core's unique design. The Magic Straw is a disposable module attached to the<br />
pump as part of the administration set. It has a built-in dual safety feature, providing automatic anti-free<br />
flow protection and upstream/downstream occlusion protection. The Magic Straw is easy to install, and<br />
its unique design prevents incorrect installation of the tubing.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Initiate business dicussions for distribution of Q Core products in various<br />
territories in Europe<br />
Distributors for infusion pumps and medical devices<br />
France, UK, Spain, and the rest of Europe<br />
42
Shekel Scales Ltd.<br />
Back to TOC<br />
Company at a Glance<br />
www.shekelonline.com<br />
Shekel is a leading manufacturer and developer of scales and weighing solutions, providing thousands of<br />
customers worldwide with innovative retail, health care and OEM smart weighing solutions.<br />
With over 35 years of experience, Shekel partners with leading companies in the industry, including GE<br />
Health Care, IBM, Fujitsu, Data Logic, and many others.<br />
Since its inception, Shekel has grown steadily to establish its position as a significant innovation leader in<br />
the market. Shekel's outstanding combination of sophisticated software and core weighing engineering<br />
technology enables the company to offer creative solutions for a wide range of OEM weighing needs.<br />
Shekel implements strict quality control management to ensure the highest standards of its products.<br />
Shekel's Healthweigh TM line has positioned itself as one of the leading players in the healthcare scales<br />
industry. Healthweigh products excel in very high precision results, and are designed to be userfriendly.<br />
Shekel's systems were the world’s first to be integrated into warmers and incubators used to<br />
sustain premature babies.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices, Healthcare IT<br />
Medical Equipment, Diagnostic, Monitoring, Telemedicine, Internet-based Health<br />
Information, Decision Support System, Services<br />
General Health, Cardiovascular, Diabetics, Intensive Care, Primary Care, Obesity,<br />
Pediatrics, Veterinary<br />
Revenue Growth<br />
Technology & Product(s)<br />
• Shekel's products are designed for professional use, and they comply with the highest international<br />
standards, including OIML Class III and NTEP.<br />
• Shekel's physician scales are suitable for medical centers, clinics, hospitals and fitness centers. All<br />
Shekel scales are manufactured with advanced electronic technology, using environmentally friendly<br />
materials.<br />
• Shekel's professional neonatal scales are ergonomically designed for the newborn baby, and they<br />
include unique movement compensation technology that ensures highest accuracy, even when the<br />
baby moves during the weighing process.<br />
• Healthweigh TM , a wide range of scales for special needs, is the most professional solution for the<br />
needs of diverse medical sectors. Equipped with easy-to-access ramps, a simple and easy to activate<br />
key pad, pressure reducing cushioned seats and more, this range is oriented for extreme comfort,<br />
ease of operation and, most importantly, for protecting patient safety.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
1. Distributors of: medical devices for hospitals, clinics, physicians, long-term care<br />
equipment suppliers, and fitness centers (nationwide distributors, or very large<br />
regional distributors).<br />
2. Medical device manufacturers requiring embedded professional weighing<br />
systems.<br />
United States; United Kingdom; Europe (Germany: for OEM embedded solutions);<br />
Japan; Korea; China; India; Australia; New Zealand; Brazil<br />
43
Sialo Technology <strong>Israel</strong><br />
Back to TOC<br />
Company at a Glance<br />
www.sialotechnology.com<br />
Sialo Technology Ltd. provides medical solutions for the treatment of salivary gland diseases and other oral<br />
conditions. Sialo's flagship technology, salivary gland endoscopy, provides an accurate means of diagnosing<br />
and locating oral obstructions, such as salivary gland stones, and permits minimally invasive oral surgical<br />
procedures.<br />
The company's most exciting development – root canal endoscopy – is expected to have a significant impact<br />
on the dental market<br />
Sialo was founded in October 2002 and has been a publicly traded company listed on the Tel Aviv Stock<br />
Exchange (SALO) since February 2007<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Diagnostics, Endoscope and Accessories<br />
Dental, Ear Nose and Throat (ENT), Oral Care<br />
Initial Revenues<br />
Technology & Product(s)<br />
Sialo's endoscope solutions are marketed globally and allow doctors to perform minimally invasive<br />
procedures in their clinics in cases that previously required full surgery and gland removal. The company<br />
offers drains and balloons for use on salivary glands; Lithotripter, an extracorporeal shock wave therapy<br />
treatment for salivary gland disorders; and Salivascope, an endoscope system for the treatment of salivary<br />
glands.<br />
Sialo Technology offers a full product line of FDA approved disposable items – drains, balloons and baskets<br />
— used with advanced endoscopic techniques. Sialo also markets high quality, compact lithotriptors, both<br />
with and without an ultrasound unit, for breaking stones into small pieces.<br />
The company's most exciting development – root canal endoscopy – is expected to have a significant impact<br />
on the dental market. Sialo offers a tiny endoscope to enable improved visibility of the area under treatment,<br />
thereby markedly increasing the success rate of root canal procedures and preventing secondary<br />
complications. Potential applications include the detection of throat and mouth cancer.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Begin worldwide marketing by cooperation with distributors.<br />
Worldwide distributors.<br />
Worldwide<br />
44
Signal Business Development<br />
Back to TOC<br />
Company at a Glance<br />
www.signalbd.com<br />
Signal Business Development, a member of The Trendlines Group, leads the US business development efforts<br />
of non-US medtech companies to accelerate their penetration into the US market. Our extensive knowledge<br />
and experience as well as our contacts all along the value chain that brings medtech products to the US<br />
market, consistenly bring results in the form of deal-oriented success.<br />
A trusted company since 1993, our experienced in-house consulting team in the US and in our EMEA office<br />
in <strong>Israel</strong> leverages an extensive network of business and investment contacts to deliver: partner<br />
development (beta/clinical sites, distribution, OEM, licensing); sales channel development (strategic<br />
customers, trade show assistance, building rep networks); market studies; market strategy plans; business<br />
plans, investor presentations; English-language marketing communications (websites, brochures,<br />
newsletters, etc.).<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Services<br />
Business Development<br />
Revenue Growth<br />
Technology & Product(s)<br />
Our experienced consulting team researches markets to build industry maps, explore the competitive<br />
landscape, and show you the "bigger picture."<br />
We analyze your venture’s strengths and weaknesses to recommend sensible business models<br />
benchmarked to your industry and market.<br />
We plan your US market entry or expansion strategies and work together to formulate your business<br />
development roadmap.<br />
To implement your plans, we identify qualified opportunities, make introductions, organize your business<br />
trip, and follow up until the deal is closed.<br />
We develop fund-raising tools with you: a well thought out business plan that maximizes your venture’s<br />
value, a compelling investor presentation, and a door-opening "one-pager." We will coach you in your<br />
presentation delivery. And we will introduce you to our growing network of investors.<br />
We develop corporate identity briefs and write on-target marketing communications materials – all to drive<br />
your great venture forward.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Sell our proven abilities to bring non-US medtech companies into the US market<br />
Medtech companies already selling product into non-US markets that see the US<br />
market as a strategic business opportunity<br />
Western European countries<br />
45
Sion Biotext Medical<br />
Back to TOC<br />
Company at a Glance<br />
www.sb-medical.com<br />
Sion Biotext Medical Ltd. is leading manufacturer of single-use skin cleansing and treatment, wound care<br />
and surgical solutions for the professional health care sector.<br />
The rich product formulations provide additional values, in the cost per unit as well as the volumes needed<br />
for each usage. Sion Biotext Medical provides the products in a variety of package sizes and dispensing<br />
options, each one designed to address specific uses and needs.<br />
Our products are nurse orientated although technology is driving physician interest. We seek to reduce the<br />
cost of healing to the healthcare provider.<br />
The company’s Quality System is accredited to ISO 9001, ISO 13485 and GMP regulations. The products bear<br />
the CE mark certification.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Disposable, Implantable<br />
Cardiovascular, Infection Control, Ophthalmology, Orthopedic, Wound Management<br />
Revenue Growth<br />
Technology & Product(s)<br />
Cleansing & Care Line offers a wide range of skin antisepsis products used to minimize infections caused by skin<br />
pathogens, and includes:<br />
Chlorhexidine (0.5%) & Alcohol Prep Pads<br />
Chlorhexidine (2%) & Alcohol Prep Pads<br />
Alcohol Prep Pads and Swabsticks<br />
Lemon Glycerin Swabsticks<br />
Electrode Skin Prep Pads<br />
Adhesive Tape Remover Pads<br />
SkinCoat Prep Pads<br />
Skin Care and Patient Treatment products are delivered in pharmaceutical-grade bases and serve to protect the<br />
skin and maintain optimal skin integrity, and includes:<br />
Sterile Lubricant Jelly<br />
First Aid Ointments and Creams<br />
Zinc Oxide, Vitamin A&D Ointment<br />
Vitamin A&D Ointment<br />
Petrolatum Ointment<br />
Cooling Gel<br />
Wound Care Line combining the traditional bandage and the impregnated technology resulted a new age product<br />
line: Zinc/Calamine Paste Bandages for the management of venous leg ulcers and ICE COOL Elastic Bandage, a<br />
revolutionary product designed to deliver cold and compression to the afected area for treatment of sport<br />
injuries, bruises, inflamations and sprains.<br />
Surgical Line offers complete solution in the operating theater by providing products such as drapes, packs and<br />
staff clothing, customised procedure packs/trays.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Distribution, Alliances<br />
Clinics, Hospitals, Home Care<br />
Europe, US, Canada, <strong>South</strong> America, Australia<br />
46
SPO Medical Systems Ltd.<br />
Back to TOC<br />
www.spovitalsigns.com<br />
Company at a Glance<br />
SPO Medical Systems Is a medical company that develops and manufactures monitoring devices that capture<br />
vital signs using patented reflective technology.<br />
SPO Medical Systems has developed a unique Reflectance Pulse Oximetry (RPO) technology for noninvasively<br />
monitoring blood oxygen saturation and heart rate. The sensors are affixed to a single side of a<br />
body part, use low-power batteries, and incorporate wireless functionality. Partners are sought to distribute<br />
and provide technical support for current product lines within four key markets: Medical care; Home and<br />
remote-care; Sports and wellness; and Safety and security.<br />
Our non-invasive reflective technology provides cutting edge, rapid and reliable mobile response, using this<br />
features we developed a new sophisticated product to preventing suicides among prisoners and mentally<br />
ills.<br />
The product is used by the <strong>Israel</strong> Prison Service.<br />
Category, Sub-category & Therapeutic Area(s)<br />
Category:<br />
Sub Category:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Monitoring<br />
General Health<br />
Revenue Growth<br />
Technology & Product(s)<br />
There are two methods to measure pulse oximetry: by transmission through a body part or by reflection. In<br />
general, the transmission method can only be used on limited areas of the body, such as fingers, earlobes,<br />
etc. Furthermore, in some instances when the transmission method is used, physiological conditions such as<br />
stress and temperature can affect the accuracy of pulse oximetry readings.<br />
SPO Medical Systems has developed patented sensors that work accurately during physical activity. This<br />
technique uses a reflective method whereby a very small sensor placed on the body at various locations has<br />
the ability to measure oxygen saturation and heart pulse rate.<br />
Innovative aspects and main advantages:<br />
• The sensor technology very precisely captures vital cardiovascular parameters such as pulse rate, pulse<br />
rhythm and pulse pressure.<br />
• It consumes very little power, so it is useful for continuous monitoring of people in non-clinical<br />
environments.<br />
• It does not require tight skin contact. Therefore, it does not cause occlusion or discomfort and can be<br />
worn comfortably around the clock for long periods of time. It is small and lightweight enough to be<br />
easily embedded in wristwatch-type devices.<br />
Goal<br />
Objectives:<br />
Target businesses:<br />
Target Countries:<br />
Looking for distributors and cooperation to embeded our technology in other<br />
potential products.<br />
USA, Europe, All Countries<br />
47
Talshir Medical Technologies<br />
Back to TOC<br />
www.talshir.co.il<br />
Company at a Glance<br />
Talshir Medical Technologies Ltd., founded in 2008, is an exclusive licensed manufacturer and marketer of<br />
NeuroVision – a technology that enhances vision neurologically and is used to improve and correct<br />
various visual impairments.<br />
NeuroVision was developed in <strong>Israel</strong>, where the company was established in 1999 by Dr. Uri Polat, a brain<br />
scientist from the Weizmann Institute of Science. In August 2001, NeuroVision received FDA 510(K)<br />
approval for the treatment of Adult Amblyopia (lazy eye), which until then has been considered untreatable.<br />
The company relocated to Singapore in 2004 under the company name NeuroVision, Inc. due to government<br />
interest in the treatment of pediatric myopia in the Asia-Pacific Region. During this time, the technology has<br />
successfully treated more than 3,000 patients in Europe, the US, and Asia. In 2009, NeuroVision was<br />
purchased by RevitalVision LLC, and operations were relocated to the United States in Kansas City, Kansas.<br />
The company's studies have been published in multiple peer reviewed scientific publications. Awareness and<br />
recognition of the company and the technology is consistently increasing in the US and worldwide.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Medical Equipment<br />
Ophthalmology<br />
Revenue Growth<br />
Technology & Product(s)<br />
The NeuroVision technology is a non-invasive, patient-specific, perceptual learning program based on<br />
visual stimulation. It facilitates neural connections at the cortical level through a computerized visual<br />
training regime using Gabor patches, to improve contrast sensitivity and visual acuity. As visual perception<br />
depends on both the optical input received from the eye and the neural processing of that input in the visual<br />
cortex, NeuroVision technology improves quality of vision (contrast sensitivity and visual acuity) by<br />
enhancing neural processing in the primary visual cortex.<br />
The NeuroVision training system is interactive web-based computer software that provides a series of<br />
individualized visual stimuli, which are designed to enhance the neural interactions in the visual cortex. The<br />
treatment is sold only through eye doctors, who examine and monitor the patient's progress.<br />
The average vision improvement is more than 2 lines on the visual acuity eye chart and 100% increase in<br />
contrast sensitivity.<br />
Neurovision is the only clinically proven and FDA approved therapy for Amblyopic Adults. The program is also<br />
used to treat Low Myopia, Early Presbyopia, Post Cataract, Post LASIK (laser) and Low Vision patients. FDA &<br />
CE-Mark approved.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Find distributors in Europe, Asia and the Middle East.<br />
Distributors<br />
Europe, Asia and the Middle East<br />
48
TavTech Ltd.<br />
TavTech<br />
www.tav-tech.com<br />
Back to TOC<br />
Company at a Glance<br />
TavTech Ltd. is an innovator of state-of-the-art technology, incorporating jet aviation principles and<br />
engineering. TavTech's unique systems use only natural components - air (or medical gas) and water -<br />
accelerated to supersonic speeds to achieve the desire effect on tissue. The technology is patented and has<br />
broad application across the medical spectrum.<br />
Aesthetic Medicine and Cosmetology – TavTech's industry-leading exclusive technology brings new<br />
dimensions to Aesthetic Medicine. TavTech's JetPeel TM systems provide multi-functional skin rejuvenation<br />
using nature's own elements – air, oxygen (or other medical gas) and saline solution. They are designed for<br />
skin rejuvenation, facial resurfacing, removal of age and hyperpigmentation spots, peri-oral wrinkles, facial<br />
deep cleansing (pores, comedones) and moisturizing, and for use on scars, acne, stretch marks, scalp and a<br />
variety of other applications, all painlessly.<br />
TavTech has launched a new product – Jet-M – that is perfectly positioned to meet the needs of the changing<br />
market. Jet-M will provide non-traditional physicians, medspas, and para-medical practitioners with<br />
affordable, multi-function treatment procedures for the aesthetic market (Please visit our website www.tavtech.com)<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Medical Equipment<br />
Dermatology and Aesthetics<br />
Revenue Growth<br />
Technology & Product(s)<br />
Jet aviation engineering is being used by TavTech to meet the needs of the rapidly expanding aesthetic, skin<br />
care and wound management markets. TavTech's patented technology creates a supersonic, two-phase jet<br />
of micro-droplets consisting of saline solution and gas (air or medical gas) that is accelerated to velocities<br />
that reach 200m/sec., providing a versatile and precise means for performing a wide variety of skin<br />
treatments.<br />
The pressure created by the high-velocity jet stretches the skin at the point of contact, causing<br />
"barophoresis" due to pressure variance; the skin in the high-pressure zone forms a concave surface and<br />
micro-canals in the outer layer of the skin broaden as the skin stretches and new canals are created. This<br />
process facilitates hydration, cleansing and purifying of the treated area, opens access to the skin's inner<br />
layers, allowing for deeper penetration, and the introduction of vitamins, anti-aging and other solutions.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Identify Partners/Distributors<br />
Qualified Partners/Distributors<br />
Germany, Australia, France<br />
49
VitalCare Medical<br />
Back to TOC<br />
www.vitalcaremedical.com<br />
Company at a Glance<br />
VitalCare Medical is pioneering the development of advanced, non-invasive software diagnostic<br />
technologies that address complex, extensive cardiac data acquisition and analysis challenges with broad<br />
potential applications.<br />
Established in 2008 by a team of world-renowned scientists, the company's headquarters are based in<br />
<strong>Israel</strong>. The company's flagship HC-100 system received CE-Mark and ISO 13485:2003 certification, and is<br />
currently being tested in large-scale retrospective studies in Europe and the US, and a prospective study in<br />
<strong>Israel</strong>.<br />
Category, Subcategory & Therapeutic Area(s)<br />
Category:<br />
Subcategory:<br />
Therapeutic Area(s):<br />
Company Status:<br />
Medical Devices<br />
Diagnostic<br />
Cardiovascular<br />
Initial Revenues<br />
Technology & Product(s)<br />
The company's flagship HeartCheck-100 (HC-100) is a patent-pending diagnostic technology that<br />
calculates and generates an HRV parameter that offers potentially powerful predictive and prognostic value.<br />
It is currently being tested for use by physicians as a cost-effective gateway test for patients at risk for<br />
ventricular tachycardia, congestive heart failure, and cardiac arrhythmia.<br />
Goal<br />
Objectives:<br />
Target Businesses:<br />
Target Countries:<br />
Strategic Alliances<br />
Worldwide<br />
50
<strong>Israel</strong><br />
inspired by innovation<br />
This publication is for informational purposes only. While every effort has been made to ensure that the information is correct, The <strong>Israel</strong><br />
Export & International Cooperation Institute assumes no responsibility for damages, financial or otherwise, caused by the information herein.<br />
© September 2010 The <strong>Israel</strong> Export & International Cooperation Institute | Production: IEICI Media & Production Division | Editing: Joseph Alexander<br />
Design: Graphic Touch